Breaking News

Lonza Expands QC Testing Portfolio

Launches PyroCell MAT System for in vitro Pyrogen testing to help ensure safety of parenteral pharmaceuticals during development, manufacture and release.

By: Contract Pharma

Contract Pharma Staff

Lonza has launched the PyroCell Monocyte Activation Test System, a sustainable and reliable solution for in vitro pyrogen testing. The new offering expands Lonza’s primary cells and endotoxin testing, combined with Sanquin’s expertise in MAT production, to help ensure the safety of parenteral pharmaceuticals during development, manufacture and product release.

 The PyroCell MAT System is designed to improve upon existing methods for pyrogen detection in complex formulations, such as human va...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters